Mycophenolate Sodium is a pharmaceutical product that is sold under the brand name Myfortic. It belongs to a class of drugs known as immunosuppressants. This pharmaceutical medicine is used in conjunction with other medications to help prevent transplant organ rejection in adults who have received heart and liver transplants, as well as adults and children 3 months and older who have received kidney transplants. It is available in the form of a capsule, a tablet, a delayed-release tablet (which releases the medication in the gut), and an oral suspension (liquid). It is normally taken on an empty stomach twice a day. Following oral treatment, enteric-coated Mycophenolate Sodium is absorbed mostly in the small intestine, where it dissolves easily in the neutral pH of the intestine. About 93% of this drug is eliminated in urine and 6% excreted in feces when administered orally. Approximately 87% of the whole administered dosage is eliminated in the urine as MPAG, an inactive metabolite. This drug should not be taken concurrently with antacids containing aluminum and/or magnesium, Cholestyramine, Colestipol, or calcium-free phosphate binders (such as aluminum products, Lanthanum, Sevelamer). This pharmaceutical medicine has the potential to induce adverse effects. Some of which include stomach pain or puffiness, constipation, nausea, vomiting, having difficulties falling or staying asleep, pain in the back, muscles, or joints, and stiffness or weakening of the muscles. It is contraindicated in conditions like Shingles in patients who do not have a normal immune system, cytomegalovirus infection, fungal infection, cancer or malignancy, and impaired bone marrow function. This drug should not be used while pregnant. It has the potential to harm an unborn child. It is uncertain whether this medication is secreted in breast milk. Breast-feeding is not recommended while using this medicine due to the potential harm to the infant.

It works by lowering the immune system, allowing the body to accept the replacement kidney as if it were its own.

The generic Mycophenolate Sodium 60 Tablet Delayed Release(s), 360mg each costs an average of $407.99.

Pipelinepharma is an online global B2B marketplace that is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The Mycophenolate Sodium offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries that produce this pharmaceutical substance. Each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where Mycophenolate Sodium is already registered in.

Pipelinepharma acts as a link between pharmaceuticals consumers and manufacturers and suppliers, removing the possibility of fraud entirely. Simply enter the drug name or the generic name of the desired medicinal drug to obtain a list of all dealers with a single click. You can use filters to limit down the results to your selected country, city, or location. Choose your preferred seller and contact manufacturers to negotiate a price.

Pipelinepharma's key goal is to serve its customers with high-quality services and products. The site considers it its responsibility to uphold both parties' confidence and satisfaction, so the medicine is inspected and tested before being formally registered on the site.